The current clinical practice of pharmacogenetic testing in Europe: TPMT and HER2 as case studies

被引：57
|
作者：
Woelderink, A
Ibarreta, D
Hopkins, MM
Rodriguez-Cerezo, E
机构：
[1] European Commiss, Joint Res Ctr, IPTS, E-41092 Seville, Spain
[2] Univ Sussex, SPRU Sci & Technol Policy Res, Brighton, E Sussex, England
来源：
PHARMACOGENOMICS JOURNAL | 2006年 / 6卷 / 01期
基金：
英国经济与社会研究理事会;
关键词：
D O I：
10.1038/sj.tpj.6500341
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 7
页数：5
相关论文
共 50 条
  • [11] Current HER2 Testing Recommendations and Clinical Relevance as a Predictor of Response to Targeted Therapy
    Ballinger, Tarah J.
    Sanders, Melinda E.
    Abramson, Vandana G.
    CLINICAL BREAST CANCER, 2015, 15 (03) : 171 - 180
  • [12] Current perspectives on HER2 testing:: A review of national testing guidelines
    Bilous, M
    Dowsett, M
    Hanna, W
    Isola, J
    Lebeau, A
    Moreno, A
    Penault-Llorca, F
    Rüschoff, J
    Tomasic, G
    de Vijver, MV
    MODERN PATHOLOGY, 2003, 16 (02) : 173 - 182
  • [13] Benchmarking a large regional UK HER2 testing service against current practice guidelines
    Thomas, Jeremy
    Loane, Joseph
    Matthews, Richard
    Maxwell, Scott
    Ingman, Tim
    Beesley, Mathew
    Ferrigan, Lynda
    JOURNAL OF CLINICAL PATHOLOGY, 2017, 70 (05) : 378 - 382
  • [14] HER2 inhibition: From discovery to clinical practice
    Chang, Jenny C.
    CLINICAL CANCER RESEARCH, 2007, 13 (01) : 1 - 3
  • [15] Advances in HER2 testing
    Chen, Yun
    Liu, Liang
    Ni, Ronghua
    Zhou, Weixian
    ADVANCES IN CLINICAL CHEMISTRY, VOL 91, 2019, 91 : 123 - 162
  • [16] Pharmacogenetic Testing: Time for Clinical Practice Guidelines
    Amstutz, U.
    Carleton, B. C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (06) : 924 - 927
  • [17] Testing for HER2 status
    Hanna, W
    ONCOLOGY, 2001, 61 : 22 - 30
  • [18] Optimal HER2 testing
    Viale, Giuseppe
    EJC SUPPLEMENTS, 2008, 6 (07): : 31 - 32
  • [19] The HER2 testing conundrum
    Allison, Malorye
    NATURE BIOTECHNOLOGY, 2010, 28 (02) : 117 - 119
  • [20] Experiences from pharmacogenetic testing in clinical practice
    Eliasson, Erik
    Bertilsson, Leif
    Sjoqvist, Folke
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 487 - 488
12345